Transient antagonism of anti-CD20 monoclonal antibodies and PI3K inhibitor idelalisib in DLBCL cell lines

Zoellner, AK; Peter, N; Zimmermann, Y; Hutter, G; Hiddemann, W; Dreyling, M

Zoellner, AK (reprint author), Univ Hosp Munich, Dept Internal Med 3, Munich, Germany.

EUROPEAN JOURNAL OF HAEMATOLOGY, 2018; 101 (2): 143

Abstract

IntroductionPI3K inhibitors are evaluated for relapsed and refractory Diffuse large B-cell lymphoma (DLBCL) patients. ObjectiveAs rituximab has shown ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索